EMULaiTOR™

Secure AI‑Powered Synthetic Personas for Research and Strategy

Bring Your Audience to Life

Lumanity’s secure synthetic persona platform helps life sciences teams get closer to their audiences by transforming trusted research and internal knowledge into realistic, interactive stakeholder simulations. Built within a private, compliant AI environment, EMULaiTOR creates lifelike virtual representations that can engage in natural language conversations, emulating the behaviors, attitudes and perspectives of the people you need to understand—whether it’s patients, healthcare professionals, payers, or other stakeholders.

Secure, Flexible, and Designed for Impact

EMULaiTOR is purpose-built for life sciences teams who need secure, credible, and lifelike audience insight they can access whenever it’s needed. It keeps your stakeholders’ voices available, interactive, and ready to support decisions across the organization.

Security and compliance at the core
Your data stays in a private, Lumanity‑hosted environment with built‑in compliance safeguards
Certified excellence
Among the first pharma services companies to achieve ISO 42001 certification, reflecting our commitment to secure, responsible AI
Built for research rigor
Personas are developed and validated by market research and data science experts to ensure accuracy and realism
True‑to‑life customization
Each persona is configured with your own research and market intelligence to mirror your exact audience
Always‑on interaction
Engage in natural language conversations with personas whenever inspiration strikes or a question arises
Expert enablement and support
Our specialists guide onboarding, training, and optimization so your teams get lasting value

Elevate qualitative research with lifelike, dynamic interactions

EMULaiTOR for Live Research

To truly understand real-world decision-making, you need to see it in action. Used within primary research, EMULaiTOR acts as a powerful stimulus, recreating authentic HCP-patient dynamics that reveal richer, more realistic behaviors.

What it delivers:

  • Real-world simulation: Naturalistic, engaging scenarios for HCPs (vs. static patient descriptions)
  • Targeted insights: Personas primed with highly detailed data to accurately portray specific patient or HCP types
  • Rich data capture: Capture consultation language, advice given, and decisions made—then unpack the reasoning behind them
Case Study Dec 1, 2025
Closing the Gap Between Segmentation and Real Life
Your segments have a story to tell — are you hearing it? By using EMULaiTOR to create synthetic patients, a leading biopharma team stepped inside real HCP–patient conversations, revealing insights that transformed how they communicate in the clinic.

Your 24/7 customer consultant for ideation, planning, messaging, and training

EMULaiTOR for Ongoing Use

When research ends, valuable insight often fades into reports and presentations. EMULaiTOR can be licensed as a secure, ongoing platform for your teams—keeping your most important audience personas alive and interactive long after the research phase has concluded. It’s like having your audience in the room 24/7; ready to test, refine, or challenge your thinking whenever you need it.

What it delivers:

  • Always-on access: Secure, natural language conversations with lifelike personas whenever you need them
  • Pressure-testing: Challenge strategies, concepts, and messages against realistic audience responses
  • Strategic ideation: Use personas as an unlimited source of inspiration and iteration
  • Cross-functional value: Supports brand, strategy, marketing, and sales alignment
Case Study Nov 20, 2025
Bringing Segmentation to Life with EMULaiTOR
A global team used EMULaiTOR to bring its segmentation to life, elevating existing insights into dynamic, human‑like personas that teams could engage with directly. This made it easier to localize strategies, activate campaigns, and connect with audiences while staying true to the global vision. Learn more.
Ready to see EMULaiTOR in action?

We’ll tailor your demo to show the live research application, the ongoing licensed platform—or both.